ISSN: 2375-3005
American Journal of Microbiology and Biotechnology  
Manuscript Information
 
 
The Influence of Different Challenge Doses of Highly Pathogenic Avian Influenza on the Efficacy of Different Avian Influenza Vaccine
American Journal of Microbiology and Biotechnology
Vol.3 , No. 3, Publication Date: May 10, 2016, Page: 18-22
2036 Views Since May 10, 2016, 527 Downloads Since May 10, 2016
 
 
Authors
 
[1]    

Nourhanne M. Said, The Central Laboratory for Evaluation of Veterinary Biologics, Cairo, Egypt.

[2]    

Lamiaa M. Omar, The Central Laboratory for Evaluation of Veterinary Biologics, Cairo, Egypt.

[3]    

Ahmed A. El-Sanousi, The Virology Department, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt.

 
Abstract
 

This study aim to investigate the influence of different challenge doses of HPAIV on the efficacy of different AI vaccine was studied by use of two different types of inactivated AI vaccines H5N1, and H5N2 and their potency were evaluated by using different doses of HPAI challenge virus. Groups of specific pathogen free chicken (SPF) were vaccinated with the recommended dose of the two vaccines according to the manufacturer, and another group was kept as control. Four weeks post vaccination (DPV) both vaccinated and control chicken groups were bled for the detection of Ab titer in response to vaccination using HI (haemagglutination inhibition test). The vaccinated chicken with the two vaccines were subdivided into 4 subgroups to be challenged by the doses (104, 105, 106, 107) EID50 of HPAI challenge virus correspondingly. The results revealed that the Ab titer produced with H5N1 vaccine was 8 log-2 and 7 log2 for H5N2 vaccine. The protection percent of the vaccinated chickens was calculated for each challenge dose for each vaccine. The protection percent of the chicken vaccinated with H5N1 vaccine was 100% in case of all AIv challenge doses while it was 90% for the chicken groups vaccinated with H5N2 in cases of (104, 105, 106) challenge doses and 85% in case of (107) challenge doses. These results demonstrate that chicken vaccinated with good quality inactivated AI vaccines under good condition were protected from clinical signs (morbidity) and deaths (mortality) caused by AIv infection even with high doses.


Keywords
 

HPAIV, Challenge Dose, Immune Response, Haemagglutination Test, H5N1 and H5N2 Vaccines, Efficacy and Potency


Reference
 
[01]    

Tumpey T. M., Alvarez, R., Swayne, D. E. and Suarez, D. L. (2005): Diagnostic Approach for Differentiating Infected from Vaccinated Poultry on the Basis of Antibodies to NS1, the Nonstructural Protein of Influenza A Virus, J. Clin. Microbiol., 43 (2): 676–683.

[02]    

Capua I. and Mutinelli F. (2001): A colour atlas and text on avian influenza, - Influenza Aviaria, Testo e atlante, - Atlas sobre la Influenza Aviar. A book, edited by Ilaria Capua and Franco Mutinelli, pp. 1-236, Published by: PAPI EDITORE, Edizioni.

[03]    

Anna R. S., Darrell W. T. and James A. R. (2008): The onset of virus shedding and clinical signs in chickens infected with high-pathogenicity and low-pathogenicity avian influenza viruses Avian Pathology Volume 37, Issue 6, 2008 pages 555-577.

[04]    

Capua I. and Alexander D. J. (2004): Avian influenza: recent developments. Avian Pathol., 33, 393–404.

[05]    

Van der Goot J. A., Koch G., de Jong M. C., van B. M. (2005): Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc. Natl. Acad. Sci. U.S.A.

[06]    

Ellis T. M., Leung C. Y., Chow M. K., Bissett L. A., Wong W., Guan Y., Malik Peiris J. S., (2004): vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathol. 33: 405-412.

[07]    

Swayne D. E. (2008): Vaccines, vaccination and immunology for avian influenza virus in poultry. In: Avian influenza. Blackwell publeshers, Ames, Iowa. In press. Blackwell publishing. p. 407-451.

[08]    

Toro H, Tang D. G, Suarez, D. L, Zhang, J. and Shi Z. (2008): Protection of chickens against avian influenza with replicating adenovirus-vectored vaccine. Vaccine, 26: 2640-2646.

[09]    

Brugh M., Beard C. W., Stone H. D. (1979): Immunization of chickens and turkeys against avian influenza with monovalent and polyvalent oil emulsion vaccines. Am. J. Vet. Res.40: 165-169.

[10]    

Karunakaran D., Newman J. A., Halvorson D. A., Abraham A. (1987): Evaluation of inactivated influenza vaccines in market turkeys. Avian Dis. 31: 498-503.

[11]    

WHO (2006) World Health Organization, weekly epidemiological record, (5), 81, 41-48.

[12]    

Wood J. M, Kawaoka Y, Newberry L. A, Bordwell E and Webster R. W. (1985): Standardization of inactivated H5N2 avian influenza vaccine and efficacy against lethal A/chicken/Pennsylvania/1370/83 infection. Avian diseases: 29.867-872.

[13]    

Stone H. D. (1988): Optimization of hydrophile- lipophile balance for improved efficacy of New-castle disease and avian influenza oil emulsion vaccines. Avian diseases 32: 68-73.

[14]    

Tian G., Zeng X., Li Y., Shi J., Chen H. (2010): Protective efficacy of the H5 I nactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam. Avian Dis. 54, 287–289.

[15]    

Pfeiffer J., Suarez D. L., Sarmento L., To T. L., Nguyen T., Pantin-Jackwood M. J., (2010): Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam. Avian Dis. 54, 262–271.

[16]    

Stone H. D. (1987): Efficacy of avian influenza oil emulsion vaccines in chickens of various ages. Avian diseases 31: 483-490.

[17]    

Xie Z. X and Stone H. D (1990): immune response to oil-emulsion vaccines with a single or mixed antigens of Newcastle, Avian influenza, and infectious bronchitis. Avian diseases 34: 154-162.

[18]    

Kapczynski D. R, Esaki M., Dorsey K. M, Jiang, H, Jackwood M, Moraes M, Gardin Y. (2015): Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.2015 Feb 25; 33 (9): 1197-205. doi: 10.1016/j.vaccine.2014.12.028. Epub 2015 Jan 20.





 
  Join Us
 
  Join as Reviewer
 
  Join Editorial Board
 
share:
 
 
Submission
 
 
Membership